US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

96.94

+0.26000.27%

Post-market: 96.940.00000.00%19:30 EDT

Volume:9K

Turnover:882.27K

Market Cap:399.39M

PE:54.06

High:96.95

Open:96.84

Low:96.67

Close:96.68

52wk High:98.82

52wk Low:67.69

Shares:4.12M

Float Shares:4.12M

Volume Ratio:0.47

T/O Rate:0.22%

Dividend:1.55

Dividend Rate:1.60%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.61

PE(LYR):5.20

Loading ...

Overview Company News Filings

Amgen, Constellation, Fastly, Keel & Blackstone Shock Wall St.

Amgen Targets Autoimmune Hepatitis With New Inebilizumab Trial

Crinetics nears shareholder vote on Vertex merger

Alnylam Pharma (ALNY) Gets a Hold from Wells Fargo

Sino Biopharmaceutical Stock Falls 2.0% in Hong Kong, Underperforms Competitors

China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks

Amgen SVP Business Development Rachna Khosla Sells Common Shares Worth $1.67 Million

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Biogen (BIIB)

Alnylam Pharma (ALNY) Receives a Buy from Stifel Nicolaus

Biogen Files Form 3 Initial Beneficial Ownership Statement for Chief Legal Officer Michael Parini

Royalty Pharma and Zealand Pharma Enter into Rusfertide Funding Agreement for $100 Million

THOMSON REUTERS

Zealand Pharma Sells Rusfertide Royalty Interests to Royalty Pharma for USD 100 Million

Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says

MT Newswires Live

Small-Molecule Generic Drug CRO Firm Sees Extreme Share Price Swings, Warns of No Innovation Drug Exposure

Is Alnylam’s Mixed 2026 Guidance Reset Altering The Investment Case For Alny (ALNY)?

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Brookdale Senior Living (BKD) and Legend Biotech (LEGN)

Vertex 1Q Net Y772.00m vs Net Y658.00m

Sino Biopharmaceutical Stock Sheds 1.5% in Hong Kong, Underperforms Competitors

Amgen to Open New Science & Innovation Center in Genome Valley, Hyderabad

THOMSON REUTERS

Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/PBE/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":96.94,"timestamp":1788292800000,"preClose":96.68,"halted":0,"volume":9114,"hourTrading":{"tag":"盘后","latestPrice":96.94,"preClose":96.94,"latestTime":"19:30 EDT","volume":13,"amount":1259.92,"timestamp":1788305405313,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0026892842366569186,"floatShares":4120000,"shares":4120000,"eps":1.793292,"marketStatus":"Not Yet Opened","change":0.26,"latestTime":"09-01 16:00:00 EDT","open":96.84,"high":96.95,"low":96.665,"amount":882271.8018240001,"amplitude":0.002948,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788336000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":96.68,"sharesOutstanding":3180000,"nav":96.62604,"aum":475400116.8,"dividendRate":0.015957,"bidAskSpread":0.001816,"preHourTrading":{"tag":"盘前","latestPrice":97.83,"preClose":96.68,"latestTime":"05:50 EDT","volume":5,"amount":486.63,"timestamp":1788256220934,"change":1.15,"changeRate":0.011895,"amplitude":0.026065},"postHourTrading":{"tag":"盘后","latestPrice":96.94,"preClose":96.94,"latestTime":"19:30 EDT","volume":13,"amount":1259.92,"timestamp":1788305405313,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.470517,"impliedVol":0.1136,"impliedVolPercentile":0.0159},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4120000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.470517,"shares":4120000,"dividePrice":1.5469,"high":96.95,"amplitude":0.002948,"preClose":96.68,"low":96.665,"week52Low":67.69,"pbRate":"1.61","psRate":"232.66","week52High":98.82,"institutionHeld":0.2552,"latestPrice":96.94,"eps":1.793292,"divideRate":0.015957,"volume":9114,"delay":0,"ttmEps":1.793292,"open":96.84,"prevYearClose":82.15,"prevWeekClose":96.32,"prevMonthClose":96.68,"prevQuarterClose":89.6486,"fiveDayClose":98.7315,"twentyDayClose":91.53,"sixtyDayClose":83.4781},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659417366","title":"Amgen, Constellation, Fastly, Keel & Blackstone Shock Wall St.","url":"https://stock-news.laohu8.com/highlight/detail?id=2659417366","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659417366?lang=en_us&edition=fundamental","pubTime":"2026-08-15 21:01","pubTimestamp":1786798870,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($AMGN)), (($CEG)), (($FSLY)), (($KEEL)) and (($BX)). Here is a breakdown of their recent trades and th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/amgen-constellation-fastly-keel-blackstone-shock-wall-st?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/amgen-constellation-fastly-keel-blackstone-shock-wall-st?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089984988.USD","LU0868494617.USD","IE0002141913.USD","LU2552382215.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","BK4608","LU0058720904.USD","LU1023059063.AUD","LU0122379950.USD","LU2112291526.USD","LU2468319806.SGD","AMGN","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU2552382132.HKD","BK4139","BK4169","IE00BJJMRZ35.SGD","BK4534","BK4588","TBXU","IBBQ","BK4599","PJP","LU1571399168.USD","SG9999001440.SGD","BK4116","IE00B2B36J28.USD","BK4581","IE00B4R5TH58.HKD","LU2242646821.SGD","BIB","BK4613","IBB","LU1983299246.USD","PBE","BBH","BK4533","LU2552382058.USD","FSLY","BK4504","LU1057294990.SGD","BK4585","STZ","LU0320765992.SGD","LU0889565916.HKD","BK4559","BK4554","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659236171","title":"Amgen Targets Autoimmune Hepatitis With New Inebilizumab Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2659236171","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659236171?lang=en_us&edition=fundamental","pubTime":"2026-08-15 00:31","pubTimestamp":1786725088,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is launching a new Phase 2/3 study called “A Trial of Ineb...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-targets-autoimmune-hepatitis-with-new-inebilizumab-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-targets-autoimmune-hepatitis-with-new-inebilizumab-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","IE0002141913.USD","LU1023059063.AUD","LU1571399168.USD","PBE","IE00B4R5TH58.HKD","LU2242652126.USD","BK4585","BK4581","PJP","IBB","LU2242646821.SGD","BK4534","BIB","LU2089984988.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","BK4599","LU1983299246.USD","LU0122379950.USD","BBH","IE00BJT1NW94.SGD","IBBQ","BK4566","LU0289739699.SGD","LU1061106388.HKD","TBXU","LU0868494617.USD","LU0320765992.SGD","LU2468319806.SGD","IE0009355771.USD","LU1057294990.SGD","AMGN","BK4588","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4139","LU2112291526.USD","BK4533","LU0058720904.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659144409","title":"Crinetics nears shareholder vote on Vertex merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2659144409","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659144409?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:21","pubTimestamp":1786713691,"startTime":"0","endTime":"0","summary":"An update from Crinetics Pharmaceuticals ( ($CRNX) ) is now available. On July 6, 2026, Crinetics Pharmaceuticals agreed to merge with Vertex Pharm...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-nears-shareholder-vote-on-vertex-merger?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-nears-shareholder-vote-on-vertex-merger?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IBB","IE00B894F039.SGD","LU0320765992.SGD","GNMX","LU1093756168.USD","LU2362541513.USD","IE00B19Z3B42.SGD","VERX","LU2089984988.USD","LU1069344957.HKD","LU2362541273.HKD","LU1815336091.USD","IBBQ","IDNA","SGXZ57979304.SGD","LU0256863811.USD","SG9999001176.SGD","IE00BZ9MQY76.HKD","LU2462157665.USD","LU2324357040.USD","IE0009355771.USD","VRTX","IE00B19Z9P08.USD","LU0566484027.USD","IE00BJT1NW94.SGD","LU0079474960.USD","SG9999001176.USD","LU1778281490.HKD","MRGR","PBE","LU0109394709.USD","IE00BFTCPJ56.SGD","LU1559883803.SGD","SG9999013999.USD","LU0058720904.USD","BIB","LU1674673691.USD","BK4139","IE00BJJMRZ35.SGD","LU0889565916.HKD","IE00B19Z9Z06.USD","LU2237438978.USD","LU2362540622.SGD","LU1674673428.USD","IE00B4R5TH58.HKD","RSBA","LU1585245621.USD","BBH","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659205110","title":"Alnylam Pharma (ALNY) Gets a Hold from Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2659205110","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659205110?lang=en_us&edition=fundamental","pubTime":"2026-08-14 17:55","pubTimestamp":1786701337,"startTime":"0","endTime":"0","summary":"In a report released today, from Wells Fargo maintained a Hold rating on Alnylam Pharma, with a price target of $256.00. In addition to Wells Fargo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alnylam-pharma-alny-gets-a-hold-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alnylam-pharma-alny-gets-a-hold-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1069347547.HKD","LU2361044865.SGD","IE00B19Z3B42.SGD","FTXO","LU0070302665.USD","LU0868494617.USD","LU0477156953.USD","LU1267930490.SGD","LU0256863811.USD","LU0320765489.SGD","BK4548","IYF","LU0128525929.USD","LU0128525689.USD","LU0310800965.SGD","BK4207","LU1506573853.SGD","BK4501","LU0048573561.USD","LU0251142724.SGD","LU0683600562.USD","LU0130102774.USD","LU1791807156.HKD","LU1894683348.USD","PBE","LU1280957306.USD","ALNY","LU0882574055.USD","IE00B7SZLL34.SGD","LU0942090050.USD","LU1201861249.SGD","LU0267386448.USD","IE000M9KFDE8.USD","LU0106831901.USD","LU0310799852.SGD","BK4559","LU1074936037.SGD","TFNS","LU0417517546.SGD","KBWB","LU0130517989.USD","LU2461242641.AUD","GNMX","LU2361044949.HKD","LU0114720955.EUR","BK4582","LU0072461881.USD","BK4585","LU0787776722.HKD","PGF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659011101","title":"Sino Biopharmaceutical Stock Falls 2.0% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2659011101","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659011101?lang=en_us&edition=fundamental","pubTime":"2026-08-14 16:31","pubTimestamp":1786696260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slid 2.0% to 4.78 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.1% to 25116.85.This was the stock's fifth consecutive day of losses.Sino Biopharmaceutical Ltd. closed 48% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 1.8% and Amgen Inc. remained unchanged.Trading volume totaled 45.4 million shares, compared to the 50-day average of 98.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BK4588","BK4139","01177","BK1191","HK0000165453.HKD","IE00B2B36J28.USD","BK1589","BK4581","PJP","IE00BZ08YS42.EUR","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4534","LU0868494617.USD","PBE","BK1521","IE0009355771.USD","IE00BZ08YT58.USD","LU1061106388.HKD","LU1983299246.USD","LU2089984988.USD","LU0109394709.USD","LU2242646821.SGD","SG9999001440.SGD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU2242652126.USD","LU0889565916.HKD","BK4533","LU2468319806.SGD","LU1057294990.SGD","LU0320765992.SGD","LU1023059063.AUD","BK4599","LU0289739699.SGD","IE00BZ08YR35.GBP","BK4585","LU2112291526.USD","BIB","IBBQ","LU0122379950.USD","IE00BFTCPJ56.SGD","AMGN","IE00B4R5TH58.HKD","TBXU","BBH","BK1515","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108000527","title":"China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks","url":"https://stock-news.laohu8.com/highlight/detail?id=1108000527","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108000527?lang=en_us&edition=fundamental","pubTime":"2026-08-14 15:38","pubTimestamp":1786693102,"startTime":"0","endTime":"0","summary":"China Galaxy Securities has released a research report stating that laboratory animals are a fundamental necessity for innovative drug research and development, with deep industry barriers. Two key...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1147","APXH","BK0276","161027","601881","BK1564","SBIO","GDOC","PBE","WRND","IBB","BIOY","BBP","XLVI","GSKH","LFSC","06881","BK0188","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659195519","title":"Amgen SVP Business Development Rachna Khosla Sells Common Shares Worth $1.67 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659195519","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659195519?lang=en_us&edition=fundamental","pubTime":"2026-08-14 07:06","pubTimestamp":1786662376,"startTime":"0","endTime":"0","summary":"Amgen SVP Business Development Rachna Khosla sells common shares worth $1.67 millionAmgen SVP, Business Development Rachna Khosla sold 2,000 common shares on Aug. 11 at USD 412.57.She exercised 1,252 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL19HYFD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Amgen SVP Business Development Rachna Khosla Sells Common Shares Worth $1.67 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU2468319806.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IBBQ","LU2242652126.USD","BK4585","IE00BJJMRZ35.SGD","PJP","TBXU","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0122379950.USD","IE0009355771.USD","BK4533","IE00BFTCPJ56.SGD","LU2112291526.USD","LU0868494617.USD","LU0320765992.SGD","BK4588","IE0002141913.USD","BK4566","LU1571399168.USD","BK4599","LU1023059063.AUD","LU2242646821.SGD","PBE","LU1061106388.HKD","LU0289739699.SGD","BK4534","IBB","LU0889565916.HKD","SG9999001440.SGD","AMGN","BIB","LU1983299246.USD","BK4139","LU2089984988.USD","BBH","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659166348","title":"Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Biogen (BIIB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166348?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:00","pubTimestamp":1786636814,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Apogee Therapeutics (APGE) and Biogen (BIIB). Apog...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE","LU0320765992.SGD","LU0128526141.USD","LABU","BK4581","BK4533","HCSG","PBE","IE00B894F039.SGD","LU0234570918.USD","LU0109394709.USD","LU0889565916.HKD","BK4585","BIIB","BK4139","BK4137","SBIO","BK4532","LU0029874061.USD","BK4588","IE00B19Z9P08.USD","XBI","XLV","BMED","IE00B19Z9Z06.USD","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659245165","title":"Alnylam Pharma (ALNY) Receives a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2659245165","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659245165?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:35","pubTimestamp":1786635358,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Alnylam Pharma today and set a price target of $318.00. According to TipRanks, Matt...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alnylam-pharma-alny-receives-a-buy-from-stifel-nicolaus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alnylam-pharma-alny-receives-a-buy-from-stifel-nicolaus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","PBE","SF","LU0109394709.USD","LU0889565916.HKD","BK4139","GNMX","LU0114720955.EUR","BK4127","BK4548","LU0320765992.SGD","ALNY","BK4585","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659218845","title":"Biogen Files Form 3 Initial Beneficial Ownership Statement for Chief Legal Officer Michael Parini","url":"https://stock-news.laohu8.com/highlight/detail?id=2659218845","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659218845?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:51","pubTimestamp":1786567875,"startTime":"0","endTime":"0","summary":"Biogen files Form 3 initial beneficial ownership statement for Chief Legal Officer Michael PariniBiogen filed a Form 3 showing Chief Legal Officer Michael Parini as a reporting insider as of Aug. 3, 2","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL2TBNSt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9P08.USD","LU0889565916.HKD","BK4532","PBE","BK4585","BK4588","IE00B19Z9Z06.USD","BIIB","IE00B894F039.SGD","LU0109394709.USD","BK4533","LU0320765992.SGD","BK4139","BMED","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659070939","title":"Royalty Pharma and Zealand Pharma Enter into Rusfertide Funding Agreement for $100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659070939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659070939?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:10","pubTimestamp":1786565400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA7DFJ4P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IHE","PBE","BK4007","RPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659074339","title":"Zealand Pharma Sells Rusfertide Royalty Interests to Royalty Pharma for USD 100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659074339","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659074339?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565156,"startTime":"0","endTime":"0","summary":"Zealand Pharma sells rusfertide royalty interests to Royalty Pharma for USD 100 millionZealand Pharma sold its economic interests tied to rusfertide to Royalty Pharma for USD 100 million in a royalty ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL6vP8kn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","PBE","BK4585","NDAQ","LU2095319765.USD","SG9999014039.USD","IE00B3QW5Z07.USD","SG9999014013.SGD","IE00BGHQF748.EUR","IHE","BK4588","LU2210150020.SGD","RPRX","LU2210149790.SGD","BK4007","IE00BKPKM429.USD","SG9999014005.SGD","BK4112","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","IE00BN0W2W23.USD","SG9999014021.USD","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658290503","title":"Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658290503","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658290503?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:02","pubTimestamp":1786546971,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals  has multiple potential catalysts coming from its portfolio that provide a net positive risk-reward profile for the company, RBC Capital Markets said in a Wednesday note.The company is expected to present results from its phase 1 study of VX-828 in patients with cystic fibrosis in H2, with a positive readout potentially strengthening its competitive advantage in the space, RBC analysts said.Favorable data will likely result in modest upside, while unfavorable data will likely lead to little downside, the analysts added.Meanwhile, approval by the US Food and Drug Administration for Vertex's povetacicept in immunoglobulin A nephropathy, with a PDUFA date of Nov. 30, 2026, is likely due to strong interim phase 3 results, the analysts said.They said that the drug's differentiated profile could make it the preferred choice of most doctors.With Sionna Therapeutics  failing to demonstrate significant sweat chloride improvements as an add-on to Trikafta, one of the more ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2417539215.USD","LU0058720904.USD","IE00B19Z3B42.SGD","IE00B2B36J28.USD","BIB","LU1093756325.SGD","LU2362541273.HKD","BK4532","BK4139","BK4567","IBB","PBE","BK4588","IE00BJT1NW94.SGD","BK4023","LU2362540622.SGD","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","IDNA","LU2237438978.USD","BK4585","LU0079474960.USD","SGXZ57979304.SGD","IE00BJJMRZ35.SGD","LU0109394709.USD","LU1674673691.USD","SG9999013999.USD","LU0566484027.USD","VRTX","LU1430594728.SGD","IBBQ","IE00B19Z9P08.USD","BBH","LU2324357040.USD","LU2362541513.USD","BK4533","IE00B19Z9Z06.USD","LU1778281490.HKD","TBXU","VERX","LU0061475181.USD","LU1815336091.USD","IE00BZ9MQY76.HKD","LU0417517546.SGD","LU0889565916.HKD","LU2456880835.USD","GNMX","SION","LU1069344957.HKD","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142463773","title":"Small-Molecule Generic Drug CRO Firm Sees Extreme Share Price Swings, Warns of No Innovation Drug Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=1142463773","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142463773?lang=en_us&edition=fundamental","pubTime":"2026-08-12 22:10","pubTimestamp":1786543834,"startTime":"0","endTime":"0","summary":"Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd. (600721.SH) issued a statement on August 12, revealing that its stock price has experienced an unusual surge, with cumulative closing price gains exceeding...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0102","BK4588","IBB","GDOC","LFSC","BBP","GSKH","BK4585","600721","BK0216","WRND","SBIO","APXH","BIOY","PBE","XLVI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908275","title":"Is Alnylam’s Mixed 2026 Guidance Reset Altering The Investment Case For Alny (ALNY)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908275","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908275?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:26","pubTimestamp":1786537582,"startTime":"0","endTime":"0","summary":"In the second quarter of 2026, Alnylam Pharmaceuticals reported revenue of US$1,290.95 million and net income of US$164.49 million, a shift from a net loss a year earlier, and for the first half of 2026 revenue reached US$2,458.12 million with net income of US$370.49 million. \nOn the same day, the company trimmed its full-year 2026 guidance for total net product revenues while raising expectations for collaboration and royalty income, highlighting a changing balance between its own drug...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alny/alnylam-pharmaceuticals/news/is-alnylams-mixed-2026-guidance-reset-altering-the-investmen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alny/alnylam-pharmaceuticals/news/is-alnylams-mixed-2026-guidance-reset-altering-the-investmen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GNMX","ALNY","LU0114720955.EUR","PBE","BK4548","LU0882574055.USD","LU0109394709.USD","BK4585","LU0889565916.HKD","BK4588","LU0320765992.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974863","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Brookdale Senior Living (BKD) and Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974863?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:10","pubTimestamp":1786533037,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Brookdale Senior Livi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-brookdale-senior-living-bkd-and-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-brookdale-senior-living-bkd-and-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1815336091.USD","LU0058720904.USD","IBBQ","IE0002270589.USD","LU1430594728.SGD","LU1499592464.USD","LU1778281490.HKD","XLV","LU2417539215.USD","LABU","BKD","SG9999001176.USD","LU1674673691.USD","HCSG","LU0432979614.USD","BK4532","CANC","IBB","MEMS","VERX","LU0029874061.USD","LU0079474960.USD","BK4185","VRTX","IE00B19Z3B42.SGD","LEGN","LU2462157665.USD","IE00B894F039.SGD","MEDI","XBI","TBXU","IE00BZ9MQY76.HKD","GNMX","BK4505","LU0061475181.USD","LU0234570918.USD","LU2237438978.USD","LU0757428866.USD","LU2089984988.USD","LU1035775433.USD","BBH","LU0417517546.SGD","BIB","IDNA","LU1585245621.USD","LU2468319806.SGD","PBE","SG9999001176.SGD","IE00B19Z3581.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658414920","title":"Vertex 1Q Net Y772.00m vs Net Y658.00m","url":"https://stock-news.laohu8.com/highlight/detail?id=2658414920","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658414920?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:41","pubTimestamp":1786524060,"startTime":"0","endTime":"0","summary":"Results are based on Japanese accounting standards.This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNMX","PBE","IE00B19Z9Z06.USD","LU2468319806.SGD","LU0889565916.HKD","TBXU","LU0757428866.USD","LU2456880835.USD","BK4588","LU0566484027.USD","IE00B894F039.SGD","LU0289739699.SGD","LU1778281490.HKD","VERX","IBBQ","BK4585","LU2237438978.USD","BK4567","LU2089984988.USD","IBB","SG9999001176.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","LU0432979614.USD","LU0823416689.USD","LU1674673691.USD","LU0079474960.USD","LU1674673428.USD","IE0009355771.USD","LU0058720904.USD","IE0002141913.USD","VRTX","BBH","BIB","LU1035775433.USD","LU0256863811.USD","LU2362541513.USD","LU1815336091.USD","SGXZ57979304.SGD","LU0234570918.USD","IE00BJJMRZ35.SGD","IE00BZ9MQY76.HKD","BK4023","LU2462157665.USD","SG9999013999.USD","SG9999001176.SGD","IE00B19Z9P08.USD","LU1093756325.SGD","IDNA","LU1430594728.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658920953","title":"Sino Biopharmaceutical Stock Sheds 1.5% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2658920953","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658920953?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:33","pubTimestamp":1786523580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slid 1.5% to 4.93 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.8% to 25440.17.This was the stock's third consecutive day of losses.Sino Biopharmaceutical Ltd. closed 46% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.3% and Amgen Inc. remained unchanged.Trading volume totaled 51.4 million shares, compared to the 50-day average of 99.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU0320765992.SGD","IE00BFTCPJ56.SGD","BK4599","IE00BZ08YT58.USD","LU1571399168.USD","BK4139","BK4534","LU1023059063.AUD","IE00BJJMRZ35.SGD","TBXU","HK0000165453.HKD","LU2242652126.USD","IE00BZ08YS42.EUR","LU0058720904.USD","IBBQ","LU0109394709.USD","BIB","BK4566","IE00B2B36J28.USD","LU0122379950.USD","LU0868494617.USD","LU0889565916.HKD","LU2089984988.USD","BK4581","BK1589","IE0009355771.USD","BK1515","BK4585","IE00B4R5TH58.HKD","BK1521","SG9999001440.SGD","BBH","IBB","LU1983299246.USD","LU2242646821.SGD","IE00BZ08YR35.GBP","LU2112291526.USD","LU2468319806.SGD","BK1191","IE00BJT1NW94.SGD","LU1057294990.SGD","LU1061106388.HKD","PJP","AMGN","BK4588","PBE","01177","LU0289739699.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658277549","title":"Amgen to Open New Science & Innovation Center in Genome Valley, Hyderabad","url":"https://stock-news.laohu8.com/highlight/detail?id=2658277549","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658277549?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:26","pubTimestamp":1786523176,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4490HP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4599","LU2468319806.SGD","IBBQ","BIB","LU1023059063.AUD","IE0009355771.USD","IE0002141913.USD","IE00B2B36J28.USD","LU2112291526.USD","BBH","LU0058720904.USD","LU0320765992.SGD","BK4585","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU0109394709.USD","LU0122379950.USD","TBXU","LU0889565916.HKD","LU2089984988.USD","LU2242646821.SGD","IE00B4R5TH58.HKD","LU0868494617.USD","BK4139","LU0289739699.SGD","LU1571399168.USD","LU1061106388.HKD","PJP","IE00BFTCPJ56.SGD","BK4581","BK4566","BK4588","PBE","LU1057294990.SGD","AMGN","IBB","LU2242652126.USD","BK4533","IE00BJT1NW94.SGD","BK4534","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658945241","title":"Biogen Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2658945241","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658945241?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:00","pubTimestamp":1786482000,"startTime":"0","endTime":"0","summary":"DJ Biogen Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  slipped 1.56% to $203.89 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.32% to 7,728.20 and Dow Jones Industrial Average  falling 0.34% to 53,791.85.This was the stock's second consecutive day of losses.Biogen Inc. closed 7.20% below its 52-week high of $219.72, which the company achieved on June 29th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 0.77% to $259.80, Pfizer Inc.  fell 1.59% to $26.62, and AbbVie Inc.  rose 0.85% to $250.09.Trading volume  remained 329,545 below its 50-day average volume of 1.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 11, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BIIB","BK4139","BK4588","LU0234570918.USD","PBE","BK4585","BK4533","LU0109394709.USD","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","IE00B894F039.SGD","LU0320765992.SGD","BMED","BK4532"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}